Treace Medical Concepts (TMCI) Asset Writedowns and Impairment (2020 - 2025)
Treace Medical Concepts (TMCI) posted Asset Writedowns and Impairment of -$69000.0 for Q3 2025, down 185.19% on a QoQ basis from $81000.0 in Q2 2025, and down 139.66% year-over-year from $174000.0 in Q3 2024.
Treace Medical Concepts (TMCI) Asset Writedowns and Impairment (2020 - 2025) Analysis & Trends
Treace Medical Concepts' Asset Writedowns and Impairment history runs 6 years deep, the most recent figure standing at -$69000.0 for Q3 2025.
- Quarterly Asset Writedowns and Impairment fell 139.66% year-over-year to -$69000.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $1.1 million (down 60.6% YoY) and the FY2024 annual result came in at $2.9 million, up 579.03% from the prior year.
- Asset Writedowns and Impairment was -$69000.0 for Q3 2025 at Treace Medical Concepts, down from $81000.0 in the prior quarter.
- Across five years, Asset Writedowns and Impairment topped out at $2.0 million in Q2 2024 and bottomed at -$227000.0 in Q2 2022.
- A 5-year average of $260764.7 and a median of $156000.0 in 2021 frame the typical range for Asset Writedowns and Impairment.
- Annual changes were most pronounced in 2021 — Asset Writedowns and Impairment tumbled 150.94% — and 2024, when it soared 17300.0%.
- Treace Medical Concepts' Asset Writedowns and Impairment stood at $156000.0 in 2021, then surged by 187.82% to $449000.0 in 2022, then decreased by 20.94% to $355000.0 in 2023, then soared by 59.44% to $566000.0 in 2024, then slumped by 112.19% to -$69000.0 in 2025.
- Business Quant data shows TMCI's Asset Writedowns and Impairment at -$69000.0 in Q3 2025, $81000.0 in Q2 2025, and $500000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.73 Bn | 176.43 Bn | 6.27 Bn |
| 2 | Stryker | 128.82 Bn | 125.94 Bn | 3.81 Bn |
| 3 | Medtronic | 108.74 Bn | 99.52 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.40 Bn | 66.95 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.42 Bn | 43.74 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 28.47 Bn | 26.18 Bn | 1.98 Bn |
| 7 | Dexcom | 28.42 Bn | 27.30 Bn | 750.30 Mn |
| 8 | Smith & Nephew | 26.97 Bn | 26.40 Bn | - |
| 9 | Koninklijke Philips | 25.52 Bn | 22.39 Bn | 2.07 Bn |
| 10 | Treace Medical Concepts | 264.18 Mn | 212.33 Mn | 37.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -69,000.00 |
| Sep 30, 2025 | -69,000.00 |
| Jun 30, 2025 | 81,000.00 |
| Jun 30, 2025 | 81,000.00 |
| Mar 31, 2025 | 500,000.00 |
| Mar 31, 2025 | 500,000.00 |
| Dec 31, 2024 | 566,000.00 |
| Dec 31, 2024 | 566,000.00 |
| Sep 30, 2024 | 174,000.00 |
| Sep 30, 2024 | 174,000.00 |
| Jun 30, 2024 | 2.05 Mn |
| Jun 30, 2024 | 2.05 Mn |
| Mar 31, 2024 | 159,000.00 |
| Mar 31, 2024 | 159,000.00 |
| Dec 31, 2023 | 355,000.00 |
| Dec 31, 2023 | 355,000.00 |
| Sep 30, 2023 | 1,000.00 |
| Sep 30, 2023 | 1,000.00 |
| Jun 30, 2023 | 40,000.00 |
| Jun 30, 2023 | 40,000.00 |